Department of Veterinary and Biomedical Sciences
Bruce Walcheck: Unlocking the Mysteries of ADAM 17
If ADAM 17 enzyme can be regulated, the incidence of diseases associated with inflammation and cancer could be reduced.
Tim Johnson: Fighting Disease in the Poultry Industry
Humans and animals are intertwined and studying the condition of animals is very relevant to the human condition.
Yuying Liang: Eliminating a Deadly Vector-Borne Virus
I wanted be a scientist ever since I was little. I like discovering something new, what we don't know.
Quality and accountability are priority – one. We focus effort accordingly to best educate and train students and scientists.The Veterinary and Biomedical Sciences (VBS) Department educates students in the biomedical sciences; discovers new knowledge about animal and human health and disease through scientific research; translates new knowledge into useful applications; and communicates knowledge to scientists, health professionals, animal producers, and industry.
Veterinary and Biomedical Sciences and
Veterinary Population Medicine
Infection by the human immunodeficiency virus (HIV) that eventually leads to AIDS is presently incurable, in part because the virus hides from killer T lymphocytes. This type of white blood cell seeks out and eliminates virus-infected cells, which are commonly found in lymphoid follicles. HIV within infected cells “simmers” in these follicles for the life of an infected person, similar to burning coals in a grill. Dr. Pam Skinner and her investigative team addressed this important medical conundrum in a study published in the Journal of Virology. They examined killer T cells in lymphoid follicles of rhesus monkeys that were infected with the simian immunodeficiency virus, a cousin to the human virus. The team discovered that although there were several inhibitory factors in follicles, such as regulatory cells that suppress T cell killing, some T cells were still able to eliminate infected cells within follicles. These studies support Dr. Skinner’s present research endeavors funded by three newly-awarded NIH grants to study how to make killer T cells migrate into lymphoid follicles and potentially cure HIV infections.
by David R. Brown, VBS Vice Chair